NUWE news

Nuwellis, Inc. amended its certificate of incorporation to authorize a 1-for-9 reverse stock split to become effective on October 26, 2026. This move is a common maneuver to remove the threat of Delisting from Nasdaq.

Nuwellis, Inc. issued a common stock purchase warrant, certifying rights for a holder to subscribe for up to 100,000 shares by August 2031, subject to the terms defined in the Securities Purchase Agreement. Market relevance: Signals an execution of an equity financing or incentive plan agreed upon i…

Nuwellis completed a public offering generating $6.0 million in gross proceeds through the sale of common stock, pre-funded warrants, and Series C and D warrants. The offering expands the company's capital base to fund operations for its cardiorenal medical technology solutions.